litlas
Log inCreate account

Peter D. Senter

Active 1990–2024

Affiliations
Seagen (United States)OncoGenex Pharmaceuticals (United States)First Tee of Greater SeattleThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
ORCID
0000-0003-2748-6007
58
Papers
16,916
Citations
53
h-index
57
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Peter D. Senter1991: 2 citations1992: 3 citations1994: 3 citations1995: 1 citations1996: 4 citations1997: 2 citations1998: 1 citations1999: 2 citations2000: 2 citations2001: 1 citations2002: 8 citations2003: 14 citations2004: 24 citations2005: 90 citations2006: 89 citations2007: 124 citations2008: 157 citations2009: 154 citations2010: 104 citations2011: 184 citations2012: 211 citations2013: 267 citations2014: 307 citations2015: 370 citations2016: 321 citations2017: 298 citations2018: 195 citations2019: 679 citations2020: 645 citations2021: 449 citations2022: 373 citations2023: 352 citations2024: 611 citations2025: 425 citations2026: 18 citations1993: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

Fields

  • Medicine61.3%
  • Biochemistry, Genetics and Molecular Biology17.9%
  • Immunology and Microbiology5%
  • Materials Science5%
  • Chemistry4.8%
  • Engineering2%
  • Other3.9%

Topics

  • Monoclonal and Polyclonal Antibodies Research27.5%
  • HER2/EGFR in Cancer Research18.4%
  • CAR-T cell therapy research7.9%
  • Glycosylation and Glycoproteins Research6.2%
  • Click Chemistry and Applications5.2%
  • Peptidase Inhibition and Analysis4.6%
  • Other30.2%

Frequent coauthors

All papers

Open in search

Loading papers…

Peter D. Senter | Litlas